Bob East co-founded Westwicke is 2006. Since then, Bob has managed the firm’s strategic direction and led Westwicke's healthcare services and HCIT practice. He has worked with companies representing all aspects of the healthcare services spectrum. Bob received a BA in finance from Loyola College in Baltimore.
Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS).
Properly positioning your story within the investment community can help you build a quality, long-term shareholder base and enhance equity market value. To develop an effective investor relations strategy, you must understand how to best interact with investors, stay visible, and adapt to deliver both good news and bad.
After several years of extraordinary performance, healthcare stocks endured a challenging year in 2016. The Nasdaq Health Care and Biotechnology Indices were down almost 14 percent and more than 18 percent, respectively, year to date, through Dec. 12.
Whether you’re a leader of a public healthcare company, or a private company with plans for an IPO, carefully planned and flawlessly executed investor relations strategies are more important than ever during periods of increased scrutiny from Wall Street.
2015 was a volatile year on Wall Street, but healthcare was a source of strength and stability for investors. While most of the major indices declined, healthcare stocks returned 5.3% last year, with several sub-sectors experiencing significant outperformance (see chart below). And 78 healthcare companies went public in 2015, the most of any sector.
Last week, Histogenics became the 100th initial public offering (IPO) in the healthcare sector in 2014, with pharmaceutical and biotech companies leading the pack. Healthcare IPOs now account for close to 40 percent of all IPOs registered for the year, more than any other sector.
At Westwicke, the year has passed in a flash, with our investor relations, capital markets, and IPO advisory experts crossing multiple time zones regularly to meet with clients and attend conferences and road shows. We shared some of our experiences and key takeaways in our last blog post, “Lessons Learned in Healthcare IR from 2014.” Here, we’d like to reveal our most popular blog posts of the year — and share essential points that can help you plan for the year ahead.
Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS). It’s critical, however, to pinpoint the right city and sponsoring analyst to make the most of the trip.
Non-deal road shows involve planning and work but can deliver meaningful results. Below are what we consider the top 10 benefits.
Preparing for an initial public offering can be a daunting task. Once the process kicks off, the wheels spin faster and faster, with deadlines and opinions flying around from everyone involved. What can ease the burden and streamline the process?
Collectively, our team has helped hundreds of companies prepare for their IPOs, and seen the best and worst of what can happen during the process. We consider the year before the transaction critical and recommend these 10 must-do steps.
Tags: initial public offering, ipo, pre-ipo, wall street
When attempting to articulate the exciting things happening within a business, management teams often rely on buzzwords and catch phrases to grab investors’ attention and paint a picture of the story they’re trying to tell. The problem, however, is that relying on clichés to bulk up your remarks often has the opposite effect. Having listened to thousands of conference calls, investors have heard it all before and view those hackneyed words and phrases as verbal fluff. Listed below are ten incredibly overused buzzwords that may sound exciting to you at first, but when used with investors, will fall on deaf ears.
Over time, all management teams want to build relationships, or at least a healthy rapport, with shareholders. Consistent execution of your business plan and proper communication with current and potential shareholders can help you build credibility, which in turn can bolster your company’s valuation and even allow your management team to earn “the benefit of the doubt” when things are not easy.
Last month, we looked at the top 10 ways companies can build credibility with shareholders. This month, we consider the opposite, and explore common ways companies get into hot water. Here are the top 10 credibility busters you want to work hard to avoid.
Legendary “60 Minutes” reporter Mike Wallace once said: “If there’s anything that’s important to a reporter, it is integrity. It is credibility.” The same should be true for every management team. Credibility with The Street – both on the buy side and the sell side – is an extremely important element in a successful investor relations program. In this month’s Top 10 list, we offer simple practices that help build and maintain corporate credibility.
